Gökçe E, Beyhan M. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors. World J Radiol 2023; 15(1): 20-31 [PMID: 36721673 DOI: 10.4329/wjr.v15.i1.20]
Corresponding Author of This Article
Erkan Gökçe, MD, Professor, Department of Radiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Kaleardı Neighborhood, Muhittin Fisunoglu Street, Tokat 60100, Turkey. drerkangokce@gmail.com
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Radiol. Jan 28, 2023; 15(1): 20-31 Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors
Erkan Gökçe, Murat Beyhan
Erkan Gökçe, Murat Beyhan, Department of Radiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Tokat 60100, Turkey
Author contributions: Gökçe E designed the study; Beyhan M supervised the study; Gökçe E and Beyhan M participated in literature research and manuscript preparation, and read and approved the final version.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Tokat Gaziosmanpasa University Faculty of Medicine (20-KAEK-105).
Informed consent statement: Patients were not required to give informed consent for the study as figures from picture archiving and communication systems were studied retrospectively.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Erkan Gökçe, MD, Professor, Department of Radiology, Tokat Gaziosmanpasa University, Faculty of Medicine, Kaleardı Neighborhood, Muhittin Fisunoglu Street, Tokat 60100, Turkey. drerkangokce@gmail.com
Received: July 5, 2022 Peer-review started: July 5, 2022 First decision: September 5, 2022 Revised: September 15, 2022 Accepted: December 13, 2022 Article in press: December 13, 2022 Published online: January 28, 2023 Processing time: 195 Days and 19.3 Hours
Core Tip
Core Tip: In this study, the diagnostic features of diffusion-weighted imaging and semiquantitative and quantitative perfusion magnetic resonance imaging (MRI) parameters were evaluated in salivary gland tumors. The apparent diffusion coefficient (ADC) values of pleomorphic adenomas (PMAs) were significantly higher than those of Warthin's tumors (WTs), other benign tumors (OBTs), and malignant tumors (MTs). On semiquantitative MRI, PMAs were distinguished from all other tumors by their long Tpeak times and lack of washout. WTs had the shortest Tpeak and highest washout ratio values. For quantitative perfusion MRI parameters, the Kep value of WTs was significantly higher than those of other tumors. The Ve values of WTs and OBTs differed significantly from those of PMAs and MTs.
